Palomar and Q-MED AB Terminate International Distribution... ( BURLINGTON Mass. Jan. 8 /- P...)

Palomar and Q-MED AB Terminate International Distribution Agreement

Date:1/8/2009

BURLINGTON, Mass., Jan. 8 /PRNewswire-FirstCall/ -- Palomar Medical Technologies, Inc. (Nasdaq: PMTI), a leading researcher and developer of light-based systems for cosmetic treatments, today announced the termination of its international distribution agreement with the Swedish company Q-MED AB (OMX Nordic Exchange, Stockholm Mid Cap:QMED), a leading biotech/medical device company based in Uppsala, Sweden. The international distribution agreement was originally entered into in January 2008 with the intention that Q-MED would eventually be responsible for the marketing, advertising, promotion, sale and distribution of Palomar's professional products for aesthetic treatments outside North America.

Due to the downturn in the world-wide economic environment, Q-MED's efforts are being concentrated on their own product line of dermal fillers. Both Palomar and Q-MED agreed that Palomar will be better served by separately continuing to expand its existing distribution channel.

Joseph P. Caruso, Palomar Chief Executive Officer said, "Although we are choosing to end our distribution agreement, this was a good learning experience and we have forged a positive relationship with Q-MED that may be beneficial in the future. We believe that during these challenging economic times we will be better positioned with full control of our international distribution. We have signed up many new distributors over the past twelve months and continue to work closely with all of our distributors to help maximize their sales efforts. Territories outside North America should continue to provide growth opportunities for us as we expand our efforts."

Bengt Agerup, Q-MED Chief Executive Officer said, "By working closely with Palomar we have learned more about Palomar's top-end technological platforms and products. Consider
'/>"/>

0

GOOD

Page: 1 2 3 4 5
Related biology technology :

1. Palomar and Q-MED AB Enter Into International Distribution Agreement
2. Senesco and Harris Moran Mutually Agree to Terminate Development and License Agreement Due to Restructuring
3. Replidyne Terminates Faropenem Agreements
4. VaxGen and Raven Terminate Merger Agreement
5. Alliance Biosciences Announces Trade Mission to Singapore with Speaker Presentation at International Lab Design Seminar
6. PAREXEL International to Present at the 27th Annual JP Morgan Healthcare Conference
7. ASM International N.V. and SAFC Hitech(TM) Sign Certified Manufacturer and Partnership Agreement
8. Health Robotics Announces Partnership in the Peoples Republic of China With The Devon International Group
9. Probiotic Delivery Technology Awarded Third International Patent
10. Pressure BioSciences, Inc. and Omni International Announce Marketing, Distribution, and Technology Development Agreement
11. The International Society for Stem Cell Research Releases New Guidelines to Shape Future of Stem Cell Therapy

Post Your Comments:

Palomar and Q-MED AB Terminate International Distribution...( BURLINGTON Mass. Jan. 8 /- P...)